Breast Cancer

Papers
(The H4-Index of Breast Cancer is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”140
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can65
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud54
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients45
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients39
Patterns of ipsilateral breast tumor recurrence following partial vs. whole-breast irradiation: a retrospective comparative study of breast-conserving therapy32
Low-carbohydrate diet score and risk of breast cancer: findings from a prospective cohort study31
Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer society27
Prognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study27
Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances25
Factors associated with post acute care utilization after mastectomy for breast cancer patients23
Development of a deep learning-based automated diagnostic system (DLADS) for classifying mammographic lesions — a first large-scale multi-institutional clinical trial in Japan21
The role of C1orf50 in breast cancer progression and prognosis20
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence20
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan20
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis19
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study19
Real-world analysis of interstitial lung disease/pneumonitis in Japanese patients with breast cancer receiving trastuzumab deruxtecan18
Detection capability of the Medical Imaging Projection System for sentinel lymph node biopsy in patients with breast cancer with and without neoadjuvant chemotherapy: a retrospective study18
Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan18
0.090084075927734